TY - JOUR
T1 - Building motion models of lung tumours from cone-beam CT for radiotherapy applications
AU - Martin, James
AU - McClelland, Jamie
AU - Yip, Connie
AU - Thomas, Christopher
AU - Hartill, Claire
AU - Ahmad, Shahreen
AU - O'Brien, Richard
AU - Meir, Ivan
AU - Landau, David
AU - Hawkes, David
PY - 2013/3/21
Y1 - 2013/3/21
N2 - A method is presented to build a surrogate-driven motion model of a lung tumour from a cone-beam CT scan, which does not require markers. By monitoring an external surrogate in real time, it is envisaged that the motion model be used to drive gated or tracked treatments. The motion model would be built immediately before each fraction of treatment and can account for inter-fraction variation. The method could also provide a better assessment of tumour shape and motion prior to delivery of each fraction of stereotactic ablative radiotherapy. The two-step method involves enhancing the tumour region in the projections, and then fitting the surrogate-driven motion model. On simulated data, the mean absolute error was reduced to 1 mm. For patient data, errors were determined by comparing estimated and clinically identified tumour positions in the projections, scaled to mm at the isocentre. Averaged over all used scans, the mean absolute error was under 2.5 mm in superior–inferior and transverse directions.
AB - A method is presented to build a surrogate-driven motion model of a lung tumour from a cone-beam CT scan, which does not require markers. By monitoring an external surrogate in real time, it is envisaged that the motion model be used to drive gated or tracked treatments. The motion model would be built immediately before each fraction of treatment and can account for inter-fraction variation. The method could also provide a better assessment of tumour shape and motion prior to delivery of each fraction of stereotactic ablative radiotherapy. The two-step method involves enhancing the tumour region in the projections, and then fitting the surrogate-driven motion model. On simulated data, the mean absolute error was reduced to 1 mm. For patient data, errors were determined by comparing estimated and clinically identified tumour positions in the projections, scaled to mm at the isocentre. Averaged over all used scans, the mean absolute error was under 2.5 mm in superior–inferior and transverse directions.
U2 - 10.1088/0031-9155/58/6/1809
DO - 10.1088/0031-9155/58/6/1809
M3 - Article
SN - 0031-9155
VL - 58
SP - 1809
EP - 1822
JO - Physics in Medicine and Biology
JF - Physics in Medicine and Biology
IS - 6
ER -